Xenon Pharmaceuticals, Inc. (XENE)
52.17
+0.83
(+1.62%)
USD |
NASDAQ |
Jun 11, 16:00
52.17
0.00 (0.00%)
After-Hours: 18:16
Xenon Pharmaceuticals Total Return Price : 52.17 for June 11, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| June 10, 2026 | 51.34 |
| June 09, 2026 | 52.79 |
| June 08, 2026 | 51.21 |
| June 05, 2026 | 51.73 |
| June 04, 2026 | 52.99 |
| June 03, 2026 | 53.46 |
| June 02, 2026 | 52.30 |
| June 01, 2026 | 53.41 |
| May 29, 2026 | 54.73 |
| May 28, 2026 | 54.79 |
| May 27, 2026 | 53.90 |
| May 26, 2026 | 53.98 |
| May 22, 2026 | 54.17 |
| May 21, 2026 | 54.12 |
| May 20, 2026 | 54.68 |
| May 19, 2026 | 54.05 |
| May 18, 2026 | 53.71 |
| May 15, 2026 | 54.39 |
| May 14, 2026 | 56.00 |
| May 13, 2026 | 55.88 |
| May 12, 2026 | 55.00 |
| May 11, 2026 | 55.78 |
| May 08, 2026 | 56.44 |
| May 07, 2026 | 56.00 |
| May 06, 2026 | 58.59 |
| Date | Value |
|---|---|
| May 05, 2026 | 57.71 |
| May 04, 2026 | 57.40 |
| May 01, 2026 | 56.13 |
| April 30, 2026 | 56.04 |
| April 29, 2026 | 55.75 |
| April 28, 2026 | 54.53 |
| April 27, 2026 | 54.26 |
| April 24, 2026 | 55.24 |
| April 23, 2026 | 55.41 |
| April 22, 2026 | 56.65 |
| April 21, 2026 | 56.40 |
| April 20, 2026 | 57.09 |
| April 17, 2026 | 59.70 |
| April 16, 2026 | 58.43 |
| April 15, 2026 | 58.88 |
| April 14, 2026 | 59.35 |
| April 13, 2026 | 58.60 |
| April 10, 2026 | 58.40 |
| April 09, 2026 | 58.59 |
| April 08, 2026 | 57.54 |
| April 07, 2026 | 57.65 |
| April 06, 2026 | 56.84 |
| April 02, 2026 | 56.85 |
| April 01, 2026 | 56.69 |
| March 31, 2026 | 58.15 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Praxis Precision Medicines, Inc. | 247.93 |
| Psyence Biomedical Ltd. | 3.45 |
| AbbVie, Inc. | 224.77 |
| Aurinia Pharmaceuticals, Inc. | 15.84 |
| enGene Therapeutics, Inc. | 1.64 |